School of Medicine


Showing 1-10 of 24 Results

  • Andrei Iagaru

    Andrei Iagaru

    Associate Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center

    Current Research and Scholarly Interests Current research projects include:
    1) PET/MRI and PET/CT for Early Cancer Detection
    2) Targeted Radionuclide Therapy
    3) Clinical Translation of Novel PET Radiopharmaceuticals;

  • David Iberri, MD

    David Iberri, MD

    Clinical Assistant Professor, Medicine - Hematology

    Bio Dr. Iberri is a medical oncologist and hematologist who specializes in the treatment of hematologic malignancies. His clinical practices runs the gamut of malignant and non-malignant hematologic disorders including acute and chronic leukemias, multiple myeloma and lymphomas, and bleeding and thrombotic disorders. He is actively involved in clinical trials evaluating novel agents in hematologic malignancies. His research interests are in the development and application of biomarkers to select patients most likely to benefit from therapy.

  • Ibrahim A. Idakoji MD, MPH

    Ibrahim A. Idakoji MD, MPH

    Clinical Instructor, Radiology

    Bio Ibrahim Idakoji is a native of the Bay Area and practicing Interventional Radiologist at Stanford Medical Center who specializes in minimally invasive, image-guided percutaneous and endovascular procedures that aid in the diagnosis and treatment of complex vascular and oncologic disease. Some of his areas of interest include: treatment of both acute and chronic venous thromboembolic disease, treatment of primary and metastatic hepatic malignancy, and percutaneous pain management.

  • Juliana Idoyaga

    Juliana Idoyaga

    Assistant Professor of Microbiology and Immunology

    Current Research and Scholarly Interests The Idoyaga Lab is focused on the function and biology of dendritic cells, which are specialized antigen-presenting cells that initiate and modulate our body’s immune responses. Considering their importance in orchestrating the quality and quantity of immune responses, dendritic cells are an indisputable target for vaccines and therapies.

    Dendritic cells are not one cell type, but a network of cells comprised of many subsets or subpopulations with distinct developmental pathways and tissue localization. It is becoming apparent that each dendritic cell subset is different in its capacity to induce and modulate specific types of immune responses; however, there is still a lack of resolution and deep understanding of dendritic cell subset functional specialization. This gap in knowledge is an impediment for the rational design of immune interventions. Our research program focuses on advancing our understanding of mouse and human dendritic cell subsets, revealing their endowed capacity to induce distinct types of immune responses, and designing novel strategies to exploit them for vaccines and therapies.

  • Debra M. Ikeda, M.D., FACR, FSBI

    Debra M. Ikeda, M.D., FACR, FSBI

    Professor of Radiology (Breast Imaging)

    Current Research and Scholarly Interests My research interests are quality improvement in mammography positioning, digital breast tomosynthesis (DBT) cancer detection and imaging pitfalls, MRI-guided breast biopsy, MRI BIRADS 3 lesions, fiducial markers for Radiation Therapy, correlation of breast cancer and FDG PET imaging, percutaneous breast biopsy

  • Daniel Imler, MD

    Daniel Imler, MD

    Clinical Assistant Professor, Emergency Medicine

    Current Research and Scholarly Interests I am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.

  • Erik Ingelsson

    Erik Ingelsson

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests We are interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of cardiovascular disease. Our research is translational and interdisciplinary, combining population-based studies with molecular biology to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel drug targets.